Loading...
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis
BACKGROUND: Breast cancer tumor markers are used by some clinicians to screen for disease recurrence risk. Since there is limited evidence of benefit, additional research may be warranted. AIM: To assess the potential value of a randomized clinical trial of breast tumor marker testing in routine fol...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4018420/ https://ncbi.nlm.nih.gov/pubmed/24236631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cer.13.15 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|